Table: Fuso Pharmaceutical -2018/19 parent results

Fuso Pharmaceutical Industries

10/05/2019 05:40

May 10 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           46.07           45.90          46.20        23.20    
               (+0.4 pct)      (-1.9 pct)     (+0.3 pct)    (+1.1 pct) 
  Operating        1.26          798 mln        650 mln      400 mln   
               (+58.0 pct)     (+21.7 pct)    (-48.5 pct)  (-38.9 pct) 
  Recurring        1.28          832 mln        600 mln      400 mln   
               (+53.7 pct)     (+29.7 pct)    (-53.1 pct)  (-42.5 pct) 
  Net            894 mln         970 mln        400 mln      250 mln   
               (-7.7 pct)      (+12.6 pct)    (-55.3 pct)  (-49.3 pct) 
  EPS          101.96 yen      109.61 yen      45.57 yen    28.48 yen  
  Ann Div       80.00 yen       80.00 yen      60.00 yen               
  -Q2 Div       40.00 yen       40.00 yen      30.00 yen               
  -Q4 Div       40.00 yen       40.00 yen      30.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T